Carla Hannig

Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial

Jacobus Pfisterer, Catherine Shannon, Klaus Baumann et al. · The Lancet Oncology · 2020 · 162 citations

Medicine, Gynecology, Oncology +14

Pre- and Postoperative Capecitabine Without or With Oxaliplatin in Locally Advanced Rectal Cancer: PETACC 6 Trial by EORTC GITCG and ROG, AIO, AGITG, BGDO, and FFCD

Hans‐Joachim Schmoll, Alexander Stein, Eric Van Cutsem et al. · Journal of Clinical Oncology · 2020 · 97 citations · Full text

Medicine, Oncology, Surgery +17

Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin versus capecitabine alone in locally advanced rectal cancer: Disease-free survival results at interim analysis.

Hans‐Joachim Schmoll, Karin Haustermans, Timothy Price et al. · Journal of Clinical Oncology · 2014 · 90 citations

Medicine, Oncology, Surgery +17

Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study

Mohamad Mohty, Evangelos Terpos, María‐Victoria Mateos et al. · Clinical Lymphoma Myeloma & Leukemia · 2018 · 89 citations · Full text

Medicine, Hematology, Pharmacoeconomics +14

Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin versus capecitabine alone in locally advanced rectal cancer: First results of the PETACC-6 randomized phase III trial.

Hans‐Joachim Schmoll, Karin Haustermans, Timothy Price et al. · Journal of Clinical Oncology · 2013 · 63 citations

Medicine, Oncology, Surgery +17